Skip to main content
. 2022 Aug 11;10(8):1948. doi: 10.3390/biomedicines10081948

Figure 1.

Figure 1

Combinatory therapeutic strategies involving a systemic chemotherapeutic drug and a plant-derived compound that proved their efficiency in reversing the acquired drug resistance in CRC. OXA—oxaliplatin; 5-FU—5-fluorouracil; IRI—irinotecan: DOXO—doxorubicin; CURC—curcumin; EGCG—epigallocatechin gallate; RES—resveratrol; ↓—increased, ↑—decreased.